Enanta Pharmaceuticals Inc (ENTA)

[willyw]

A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model
https://clinicaltrials.gov/ct2/show/NCT03691623?term=enanta&rank=1
Recruitment Status : Not yet recruiting
First Posted : October 2, 2018

***********************

I will also note Enanta will release data (Clinical trials-phase 1) at an RSV conference November 1. This is the first day of the conference, possibly a poster event- doesn't appear to be a gran finale type oral presentation late breaker.

Still, it would appear that they are preparing to enter phase 2, which I *presume* means they were satisfied enough to post data at an RSV conference, and to continue setting up a Phase II trial. (as of less than a week ago)

Not a slam dunk, but generally positive indications.
The size of the trial may also be an indication; 114 participants demonstrates some degree of commitment.

Jay Luly-Enanta CEO- has mentioned RSV as a possible "go alone" possibility for ENTA- they could possibly do this without a partner.